Description
Laboratory Corporation of America Holdings (LabCorb): Expansion into Hospital & Regional Laboratory Markets & Focus on High-Growth Specialty Testing Markets!
Labcorp Holdings Inc. delivered a robust performance in the second quarter of 2024, showcasing a continued upward trajectory in its business operations. The company reported impressive figures with revenues totaling $3.2 billion, reflecting a 6% increase compared to the same period in 2023. Adjusted earnings per share (EPS) also saw an appreciable rise, reaching $3.94, signifying a 15% increase. This was supported by strong free cash flow from continuing operations, amounting to $433 million.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
